Global Vascular Closure Devices Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Million
Loading…
Share Distribution
Loading…
Market Dynamics of Global Vascular Closure Devices Market Analysis
↑ Growth Drivers
Surging Incidence of Cardiovascular Diseases (CVDs)
Shift Toward Minimally Invasive Interventions
Continuous Technological Progress in Vascular Closure Solutions
Expansion of Catheterization Labs and Interventional Infrastructure
Rising Global Aging Population
↓ Restraints
Risk of Adverse Device-Related Complications
High Upfront Cost of Vascular Closure Devices
Strict Regulatory Environment and Product Recalls
Limited Penetration in Low-Resource Settings
~ Trends
Increasing Adoption of Bioabsorbable and Biodegradable Vascular Closure Devices
Rising Demand for Large-Bore Vascular Closure Solutions
Integration of Imaging-Guided Closure Techniques
Expanding Use in Ambulatory and Outpatient Settings
Emerging Markets Driving Future Growth Opportunities
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Global Vascular Closure Devices Market Analysis — Presence
Interactive World Map
Click countries to explore
Loading map…
Regional and Country Analysis
North America — United States, Canada, Mexico
Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
Africa — East Africa, West Africa, North Africa, South Africa
Region / Country
2021 (A)
2025 (A)
2033 (P)
CAGR
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape of the Global Vascular Closure Devices Market Analysis
In no particular order of rank
The Global Vascular Closure Devices Market Analysis market is highly competitive, with players expanding through new product launches, M&A, partnerships, and regulatory approvals for advanced technologies. The report covers financials (revenue, margin, market share 2021–2033) and SWOT analysis, while also highlighting company responses to tariff challenges via supply chain shifts, production changes, and digital healthcare investments.
Click any bar or cell to request the full company profile
Company
2022 (A)
2023 (A)
2024 (A)
2025 (A)
Terumo Corporation
•••
•••
•••
•••
Abbott Laboratories
•••
•••
•••
•••
Cardinal Health Inc. (Cordis)
•••
•••
•••
•••
Cardiva Medical Inc.
•••
•••
•••
•••
Medtronic
•••
•••
•••
•••
Morris Innovative Inc.
•••
•••
•••
•••
Essential Medical Inc.
•••
•••
•••
•••
Merit Medical Systems Inc.
•••
•••
•••
•••
Vasorum Ltd.
•••
•••
•••
•••
TZ Medical Inc.
•••
•••
•••
•••
Vivasure Medical Ltd.
•••
•••
•••
•••
Inseal Medical Ltd.
•••
•••
•••
•••
Tricol Biomedical Inc
•••
•••
•••
•••
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Executive Summary of Vascular Closure Devices Market
The global Vascular Closure Devices (VCDs) market is poised for significant growth, expanding from $1692.26 million in 2021 to an estimated $3374.45 million by 2033, driven by a compound annual growth rate (CAGR) of 5.92%. This expansion is primarily fueled by the increasing prevalence of cardiovascular diseases worldwide and a corresponding rise in the volume of diagnostic and interventional catheter-based procedures. The market is also benefiting from a strong patient and physician preference for minimally invasive techniques, which reduce complications, shorten hospital stays, and improve patient recovery times. Technological advancements, particularly in the development of bioabsorbable and large-bore closure devices, are further propelling market adoption. While North America currently holds the largest market share, the Asia Pacific region is emerging as the fastest-growing market due to improving healthcare infrastructure and rising procedural volumes.
Key strategic insights from our comprehensive analysis reveal:
The market is experiencing a notable shift towards advanced technologies, with bioabsorbable and suture-mediated devices gaining traction over traditional mechanical methods due to improved safety profiles and patient comfort.
North America dominates the market landscape, but the Asia Pacific region, led by China and India, is projected to exhibit the highest growth rate, presenting significant expansion opportunities for manufacturers.
The increasing complexity of cardiovascular interventions, including large-bore access procedures like TAVR and EVAR, is creating a strong demand for specialized, high-performance closure devices capable of ensuring reliable hemostasis.
Global Market Overview & Dynamics of Vascular Closure Devices Market Analysis
The global market for vascular closure devices is characterized by steady growth, innovation, and an increasing focus on improving procedural outcomes. These devices are essential for achieving rapid and reliable hemostasis of the femoral artery access site following catheterization procedures. The market's upward trajectory is supported by the global aging population, which is more susceptible to cardiovascular conditions, and the continuous expansion of healthcare infrastructure, making advanced medical procedures more accessible across different regions.
Global Vascular Closure Devices Market Drivers
Increasing Volume of Catheter-Based Procedures: The rising incidence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, has led to a surge in the number of diagnostic angiograms and percutaneous coronary interventions (PCIs), which are primary applications for VCDs.
Patient and Provider Preference for Minimally Invasive Solutions: VCDs facilitate earlier patient ambulation, reduce recovery times, and lower the length of hospital stays compared to manual compression. This alignment with the broader healthcare trend towards minimally invasive and outpatient procedures drives their adoption.
Technological Advancements in Device Design: Continuous innovation leading to the development of safer, more effective, and easier-to-use devices, including bioabsorbable materials and devices for large-bore closure, expands the clinical utility and appeal of VCDs.
Global Vascular Closure Devices Market Trends
Shift Towards Bioabsorbable Materials: There is a growing trend of using VCDs made from bioabsorbable polymers that are fully absorbed by the body over time, leaving no foreign material behind and reducing the risk of long-term complications.
Focus on Large-Bore Arterial Closure: The increasing popularity of complex structural heart procedures like Transcatheter Aortic Valve Replacement (TAVR) and Endovascular Aneurysm Repair (EVAR), which require large-bore arterial access, is driving demand for specialized closure devices.
Expansion into Ambulatory Surgical Centers (ASCs): A growing number of catheterization procedures are being performed in outpatient settings and ASCs to reduce healthcare costs, a trend that favors the use of VCDs for efficient patient throughput and discharge.
Global Vascular Closure Devices Market Restraints
High Cost of Devices: The relatively high cost of vascular closure devices compared to traditional manual compression can be a significant barrier to adoption, particularly in cost-sensitive healthcare systems and developing economies.
Risk of Complications: Despite advancements, the use of VCDs is associated with potential complications, including infection, arterial stenosis, device failure, and embolization, which can deter their use in certain patient populations.
Stringent Regulatory and Reimbursement Hurdles: Navigating the complex and stringent regulatory approval pathways for new medical devices can be time-consuming and expensive, potentially delaying the introduction of innovative products to the market.
Strategic Recommendations for Manufacturers
Manufacturers should prioritize R&D investment in next-generation bioabsorbable and large-bore closure devices that offer superior safety and efficacy profiles to address unmet clinical needs. Strategic focus should be placed on geographic expansion into high-growth Asia Pacific markets, such as China and India, by adapting pricing and distribution strategies to local conditions. Furthermore, building strong clinical evidence to support the economic and clinical benefits of VCDs over manual compression is crucial for driving adoption and securing favorable reimbursement policies. Collaborating with key opinion leaders and providing robust training programs for healthcare professionals can accelerate the uptake of new and advanced technologies.
Detailed Regional Analysis: Data & Dynamics of Vascular Closure Devices Market Analysis
The global Vascular Closure Devices market exhibits distinct regional dynamics, with North America currently leading in market size, commanding a significant share of global revenue. However, the Asia Pacific region is forecast to be the epicenter of growth, registering the highest CAGR through 2033. This regional analysis delves into the market size, growth drivers, and specific trends shaping the VCD landscape across key geographies.
North America Vascular Closure Devices Market Analysis
Market Size: $663.705 Million (2021) -> $811.956 Million (2025) -> $1211.43 Million (2033)
CAGR (2021-2033): 5.129%
Country-Specific Insight: North America holds 38.1% of the global market share in 2025. The United States is the dominant force, accounting for approximately 27.7% of the global market. Canada and Mexico contribute significantly, holding 7.3% and 3.1% of the global market share, respectively, driven by well-established healthcare systems and high rates of cardiovascular procedures.
Regional Dynamics:
Drivers
High prevalence of cardiovascular diseases and obesity.
Advanced healthcare infrastructure and high adoption rate of new medical technologies.
Favorable reimbursement policies for catheter-based interventions.
Trends
Rapid shift of procedures to ambulatory surgical centers (ASCs).
Increasing use of VCDs in complex, large-bore structural heart procedures.
Growing preference for VCDs that reduce time-to-ambulation and hospital stays.
Restraints
Price pressure from group purchasing organizations (GPOs) and hospital consolidation.
Stringent FDA regulatory requirements for new device approvals.
Potential for litigation related to device complications.
Technology Focus
The region shows a strong preference for advanced VCDs, including suture-mediated devices and fully bioabsorbable sealant technologies. There is a significant R&D focus on developing devices that can reliably close large-bore access sites (up to 25Fr or more) required for procedures like TAVR and MitraClip, reflecting the complexity of interventions performed in this market.
Europe Vascular Closure Devices Market Analysis
Market Size: $461.988 Million (2021) -> $575.1 Million (2025) -> $884.107 Million (2033)
CAGR (2021-2033): 5.523%
Country-Specific Insight: Europe accounts for 27.0% of the global market in 2025. Germany leads the region, representing 5.95% of the global market. The United Kingdom and France follow, contributing 4.34% and 3.73% to the global market size, respectively, supported by robust national health systems and an aging population.
Regional Dynamics:
Drivers
Aging population with a high burden of chronic cardiovascular conditions.
Strong government support for healthcare and well-established national health services.
High volume of interventional cardiology procedures across the region.
Trends
Growing adoption of CE-marked innovative VCDs, including extravascular solutions.
Emphasis on cost-effectiveness and demonstrating value to national health technology assessment (HTA) bodies.
Increased focus on same-day discharge protocols for percutaneous interventions.
Restraints
Fragmented market with diverse regulatory and reimbursement systems across countries.
Budgetary constraints within national healthcare systems impacting technology acquisition.
Strong preference for traditional, lower-cost methods in some Eastern European countries.
Technology Focus
European markets are receptive to a wide range of VCD technologies, with a balance between active and passive closure systems. There is a notable trend towards extravascular devices and patch-based technologies that minimize intravascular components. The CE Mark process facilitates quicker access to market for novel devices compared to the US FDA, fostering innovation in the region.
Asia Pacific (APAC) Vascular Closure Devices Market Analysis
Market Size: $365.529 Million (2021) -> $485.64 Million (2025) -> $863.86 Million (2033)
CAGR (2021-2033): 7.465%
Country-Specific Insight: APAC is the fastest-growing region, capturing 22.8% of the global market in 2025. China is a major driver, holding nearly 8.0% of the global market. Japan and India are also key markets, contributing 4.26% and 2.95% of the global share, respectively, fueled by rapid healthcare infrastructure development and a massive patient pool.
Regional Dynamics:
Drivers
Rapidly improving healthcare infrastructure and increasing healthcare spending.
Large and growing patient populations with rising rates of lifestyle-related diseases.
Increasing medical tourism in countries like Singapore and India.
Trends
Leapfrogging to newer VCD technologies, bypassing older generations.
Growing local manufacturing capabilities, especially in China and India.
Expansion of interventional cardiology services into tier-2 and tier-3 cities.
Restraints
Significant price sensitivity and preference for low-cost alternatives like manual compression.
Lack of reimbursement for VCDs in many countries within the region.
Shortage of trained cardiologists and catheterization lab staff in rural areas.
Technology Focus
The APAC region is a mixed landscape. While major metropolitan hospitals adopt state-of-the-art bioabsorbable and large-bore VCDs, there is a substantial market for simpler, more cost-effective mechanical closure devices. The focus is on providing reliable and affordable solutions that can be widely deployed to manage the high volume of procedures.
South America Vascular Closure Devices Market Analysis
Market Size: $91.213 Million (2021) -> $116.937 Million (2025) -> $192.006 Million (2033)
CAGR (2021-2033): 6.395%
Country-Specific Insight: South America represents 5.49% of the global market in 2025. Brazil is the largest market in the region, holding 2.29% of the global share. The market is growing due to a combination of public health initiatives and a growing private healthcare sector that is adopting more advanced medical technologies.
Regional Dynamics:
Drivers
Improving economic conditions and rising healthcare expenditure.
Increasing access to both public and private healthcare services.
Growing awareness and adoption of minimally invasive procedures among physicians.
Trends
Gradual shift from manual compression to VCDs in major urban hospitals.
Development of local distribution networks by multinational companies.
Increased training and education programs for interventional cardiologists.
Restraints
Economic instability and currency fluctuations impacting purchasing power.
Inconsistent reimbursement and high out-of-pocket costs for patients.
Logistical challenges and complex import regulations for medical devices.
Technology Focus
Adoption in South America is primarily focused on proven, cost-effective VCD technologies. Suture-mediated and clip-based devices are common. The latest generation of bioabsorbable and large-bore devices is mostly limited to specialized private hospitals in major cities due to their higher cost and the need for specialized training.
Middle East Vascular Closure Devices Market Analysis
Market Size: $67.69 Million (2021) -> $85.2 Million (2025) -> $141.727 Million (2033)
CAGR (2021-2033): 6.568%
Country-Specific Insight: The Middle East accounts for 4.0% of the global market in 2025. Saudi Arabia leads the region, constituting 1.52% of the global market. Growth is driven by significant government investment in building world-class healthcare facilities and a high prevalence of diseases like diabetes and hypertension.
Regional Dynamics:
Drivers
Heavy government investment in creating state-of-the-art healthcare infrastructure.
High prevalence of risk factors for cardiovascular disease.
Demand for the latest and most advanced medical technologies from the West.
Trends
Establishment of specialized heart and vascular centers.
Adoption of premium, feature-rich vascular closure devices.
Growing medical tourism, particularly in the UAE and Saudi Arabia.
Restraints
Dependence on expatriate healthcare professionals in some areas.
Geopolitical instability in certain parts of the region.
Varying regulatory standards and tender-based procurement processes.
Technology Focus
Healthcare providers in affluent Gulf Cooperation Council (GCC) countries often demand the most advanced technologies available globally. There is strong adoption of large-bore closure devices for TAVR and other complex procedures, as well as the latest bioabsorbable VCDs. Price is less of a barrier here compared to other emerging markets.
Africa Vascular Closure Devices Market Analysis
Market Size: $42.137 Million (2021) -> $55.167 Million (2025) -> $81.324 Million (2033)
CAGR (2021-2033): 4.971%
Country-Specific Insight: Africa holds the smallest but a gradually growing share, representing 2.59% of the global market in 2025. South Africa is the most developed market on the continent, accounting for approximately 0.98% of the global share. Growth is concentrated in urban centers with developing private healthcare sectors.
Regional Dynamics:
Drivers
Gradual improvement in healthcare infrastructure in key countries like South Africa and Nigeria.
Increasing urbanization and a growing middle class with access to private healthcare.
Efforts by international organizations to combat non-communicable diseases.
Trends
Focus on cost-effective and easy-to-use medical devices.
Adoption of VCDs primarily in private hospitals and specialized public centers.
Partnerships with NGOs and international companies for training and technology transfer.
Restraints
Widespread lack of healthcare infrastructure and funding.
Severe shortage of trained medical personnel.
Cost remains the most significant barrier to adoption; manual compression is standard.
Technology Focus
The technology focus in Africa is on basic, reliable, and low-cost healthcare solutions. For vascular closure, this means the market is nascent, and VCD adoption is minimal and limited to the most affordable and simplest mechanical clip or plug-based devices in a few select hospitals.
Key Takeaways
The global Vascular Closure Devices market is on a robust growth path, projected to reach $3374.45 million by 2033, with a steady CAGR of 5.92%, primarily driven by the increasing volume of catheter-based procedures worldwide.
North America remains the largest market, holding a 38.1% global share in 2025, but the Asia Pacific region is the key growth engine, with the highest CAGR (7.465%) due to rapid healthcare development in China and India.
A definitive trend towards advanced technologies is shaping the market, with strong demand for bioabsorbable materials that leave no implant behind and specialized devices for complex, large-bore arterial closures.
Key market restraints include the high cost of VCDs compared to manual compression, which limits adoption in price-sensitive markets, and the potential risk of device-related complications that necessitates continuous innovation in safety and design.
The medical devices and consumables industry is growing rapidly, driven by aging populations, rising healthcare spending, and supportive regulations, boosting demand for implants, assistive tech, and home monitoring. Challenges include strict regulations, high R&D costs, and supply chain risks, but opportunities lie in emerging markets, health-tech partnerships, and eco-friendly devices. Key trends such as AI, precision medicine, and sustainable innovations are transforming healthcare and accelerating market growth.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Vascular Closure Devices Market Analysis is witnessing significant growth in the near future. In 2023, the Passive Approximators segment accounted for a notable share of the Global Vascular Closure Devices Market Analysis.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Vascular Closure Devices Market Analysis is witnessing significant growth in the near future.
In 2023, the Passive Approximators segment accounted for a notable share of the Global Vascular Closure Devices Market Analysis.
Supriya Yadav
Research Analyst at Cognitive Market Research · Cognitive Market Research
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Vascular Closure Devices Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers Terumo Corporation, Abbott Laboratories, Cardinal Health Inc. (Cordis), Cardiva Medical Inc., Medtronic, Morris Innovative Inc., Essential Medical Inc., Merit Medical Systems Inc., Vasorum Ltd., TZ Medical Inc., Vivasure Medical Ltd., Inseal Medical Ltd., Tricol Biomedical Inc and others are profiled in the report.
Segments include Type, Application and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.
★ Reviews
No reviews yet — be the first!
Rate this report
Global Vascular Closure Devices Market Analysis — Table of Contents
Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition
Country
Type
Passive Approximators, Active Approximators
Application
Interventional Cardiology, Interventional Radiology/Vascular Surgery
List of Competitors
Terumo Corporation, Abbott Laboratories, Cardinal Health Inc. (Cordis), Cardiva Medical Inc., Medtronic, Morris Innovative Inc., Essential Medical Inc., Merit Medical Systems Inc., Vasorum Ltd., TZ Medical Inc., Vivasure Medical Ltd., Inseal Medical Ltd., Tricol Biomedical Inc
1.1 Global Power Realignment & Strategic Alliances
17.6 Future Gross Margin Outlook and Profitability Trends
18.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study.
You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
18.2 Analyst Point of View
18.3 Assumptions and Acronyms
19.1 Primary Data Collection
19.1.1 Steps for Primary Data Collection
19.1.1.1 Identification of KOL
19.1.2 Backward Integration
19.1.3 Forward Integration
19.1.4 How Primary Research Help Us
19.1.5 Modes of Primary Research
19.2 Secondary Research
19.2.1 How Secondary Research Help Us
19.2.2 Sources of Secondary Research
19.3 Data Validation
19.3.1 Data Triangulation
19.3.2 Top Down & Bottom Up Approach
19.3.3 Cross check KOL Responses with Secondary Data
19.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Vascular Closure Devices Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Latest News about Vascular Closure Devices Market
Sources from Medical Devices & Consumables Industry
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Vascular Closure Devices Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global vascular closure devices market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
What's Included
Dedicated analyst assigned to you
Live walkthrough of findings
Strategic Q&A sessions
Go-to-market recommendations
NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
